MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment

Preeclampsia affects one in twelve of the 130 million pregnancies a year. The lack of an effective therapeutic to prevent or treat it is responsible for an annual global cost burden of 100 billion US dollars. Preeclampsia also affects these women later in life as it is a recognised risk factor for c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezai, Homira, Ahmad, Shakil, Alzahrani, Faisal A., Sanchez-Aranguren, Lissette, Dias, Irundika HK., Agrawal, Swati, Sparatore, Anna, Wang, Keqing, Ahmed, Asif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610044/
https://www.ncbi.nlm.nih.gov/pubmed/33137710
http://dx.doi.org/10.1016/j.redox.2020.101768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610044/
https://www.ncbi.nlm.nih.gov/pubmed/33137710
http://dx.doi.org/10.1016/j.redox.2020.101768

Ejemplares similares